This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Richard A. Parker, MD; Erin E. Hartman, MS

JAMA. 1998;280:2118.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

In December 1997, at Medicine Grand Rounds, Dr Mark Peppercorn, MD, discussed the range of treatment options for ulcerative colitis.¹ At that time, Mrs F, a 66-year-old woman with loose, bloody bowel movements and a diagnosis of ulcerative colitis, expressed concern about usual medications due to severe allergies. Cortenemas had lost their efficacy, and prednisone prescribed for severe asthma was of uncertain benefit for her symptoms of ulcerative colitis. Dr Peppercorn felt her disease was not severe enough to justify colectomy, but he did believe a trial with topical aspirin therapy was warranted as a next step.

MRS F, THE PATIENT

Fortunately, the bloating and loose bloody bowel movements have stopped on their own. Other than the 7.5 mg/d of prednisone for my asthma, I am taking no drugs for ulcerative colitis. I am in remission. I saw my gastroenterologist recently, and she does not feel . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?